Table 2.

The top 10 significant differentially expressed miRNAs/miRNA candidates in controls (n = 37) versus lung diseases (n = 82).

miRNA	miRCarta ID	Median control	Median lung diseases	Fold change (median control/median lung diseases)	Wilcoxon rank sum test p-value (two-tailed, FDR adjusted)
hsa-miR-30b-5p	m-76	12,131.08	2267.55	5.35	3.93E-11
hsa-miR-192-5p	m-59	828.5	196.46	4.22	3.93E-11
hsa-miR-628-3p	m-445	40.02	20.17	1.98	3.93E-11
hsa-miR-1273g-3p	m-1013	1385.5	4377.83	0.32	4.89E-11
hsa-miR-30c-5p	m-56;m-57	1165.87	208.14	5.6	7.4E-11
hsa-miR-215-5p	m-265	1016.12	296.74	3.42	7.4E-11
hsa-miR-550a-3p	m-408	296.69	64.92	4.57	1.08E-10
hsa-miR-18a-3p	m-389	21.78	6.02	3.62	1.64E-10
hsa-miR-19b-3p	m-121; m-122	2465.73	620	3.98	1.72E-10
hsa-miR-500a-5p	m-345	933.28	504.22	1.85	1.78E-10